Zerumbone (Wild Ginger Sesquiterpene Ketone · NF-κB/Nrf2 Dual Modulator · Chemopreventive)

Compound	Zerumbone
Chemical class	Terpenoid — Sesquiterpene Ketone (Humulane-type; 11-membered ring monocyclic)
CAS	471-05-6
Primary source	Zingiber zerumbet (wild ginger / shampoo ginger, rhizome essential oil)
Key applications	Anti-inflammatory; antiproliferative; chemopreventive; antioxidant; antimicrobial; availability on request
Claim strength	Moderate
Typical form	Zingiber zerumbet essential oil (zerumbone 65–75% of oil); zerumbone isolate (research grade)
Buy from Herbuno	Request availability and bulk pricing →

Name origin: From zerumbet (Arabic name for the wild ginger Zingiber zerumbet). Zerumbone is a sesquiterpene ketone — a cyclic conjugated enone (the α,β-unsaturated ketone system making it a Michael acceptor) on an 11-membered carbocyclic ring, structurally related to the humulane sesquiterpene skeleton. The α,β-unsaturated ketone (enone) is the primary pharmacophoric group — similar to the α-methylene-γ-lactone of parthenolide, it can covalently modify cysteine residues in target proteins (Keap1 for Nrf2 activation, NF-κB p65 cysteine alkylation). Traditional use: Zingiber zerumbet (wild ginger, pinecone ginger, or shampoo ginger — named for the foamy sap used traditionally for hair washing) is used across Southeast Asian, South Asian, and Pacific traditional medicine for anti-inflammatory, antimicrobial, and digestive purposes. The squeezed rhizome juice was used topically for pain and inflammation; oral preparations for digestive and respiratory conditions. Research trajectory: Zerumbone has attracted significant pharmaceutical research interest due to its potent and multi-mechanistic anti-inflammatory and chemopreventive activity, comparable to curcumin but with better oral bioavailability in some animal studies. Multiple cancer cell lines and animal models confirm antiproliferative, anti-angiogenic, and metastasis-inhibiting activity. Clinical trials have not been conducted. Commercial source: Not currently in the Herbuno catalogue. Contact Herbuno for Zingiber zerumbet extract availability.

---

Evidence for Zerumbone Applications

Anti-inflammatory — NF-κB and Nrf2 dual modulation: Zerumbone simultaneously inhibits NF-κB (reducing pro-inflammatory cytokines) and activates Nrf2 (upregulating antioxidant defence enzymes) via its reactive enone group alkylating cysteine residues in both Keap1 (Nrf2 activator) and IKKβ (NF-κB inhibitor). This dual mechanism — simultaneously reducing inflammation and increasing antioxidant capacity — is pharmacologically similar to curcumin but potentially more potent. Claim strength: Moderate (in vitro; animal).

Antiproliferative and chemopreventive: Zerumbone is one of the most extensively studied natural sesquiterpene ketones for cancer prevention. Active across colon, liver, breast, cervical, and leukaemia cell lines via apoptosis induction, cell cycle arrest (G2/M), and anti-angiogenesis (reducing VEGF expression). In animal carcinogenesis models, zerumbone reduces tumour incidence when given during the initiation or promotion phase. Claim strength: Moderate (convergent preclinical; no clinical translation).

Antimicrobial: Zerumbone is active against Mycobacterium tuberculosis and several multi-drug resistant bacteria in vitro — making it a compound of interest in TB research. MIC against M. tb is in the low micromolar range. Claim strength: Moderate (in vitro; TB relevance is significant but no clinical data).

---

Frequently Asked Questions — Zerumbone

How does zerumbone compare to curcumin for anti-inflammatory activity?
Both are Michael acceptors that alkylate Keap1 and IKKβ cysteines, simultaneously activating Nrf2 and inhibiting NF-κB. Zerumbone’s enone group (in its 11-membered ring sesquiterpene scaffold) may be more reactive as a Michael acceptor than curcumin’s β-diketone enol under physiological conditions. Zerumbone reportedly has better oral bioavailability than native curcumin in some rodent pharmacokinetic studies. However, curcumin has vastly more clinical evidence; zerumbone has essentially no human clinical data. For formulation, zerumbone is a scientifically interesting curcumin complement but not a replacement.

What makes zerumbone a potential TB drug candidate?
Tuberculosis (Mycobacterium tuberculosis) is a major global health challenge with growing multidrug resistance (MDR-TB, XDR-TB). Zerumbone’s activity against M. tb H37Rv (standard laboratory strain) at MIC 6.25–12.5 μg/mL positions it in the same range as some established anti-TB drugs. The lipophilic sesquiterpene structure could potentially enable better penetration of mycobacterial cell walls (which are extraordinarily lipid-rich). However, TB drug discovery requires extensive toxicity, pharmacokinetics, and in vivo efficacy testing before clinical candidates emerge — zerumbone is an early-stage lead.

Is Zingiber zerumbet the same as Zingiber officinale?
No — related species with very different phytochemistry. Z. officinale (common ginger) contains gingerols, shogaols, and zingiberene as primary actives. Z. zerumbet (wild ginger, shampoo ginger) contains zerumbone as its primary bioactive (65–75% of essential oil) with little to no gingerol content. The plants look similar and share the Zingiber genus but are pharmacologically distinct. Z. zerumbet is used in traditional medicine across Southeast Asia and Pacific islands for different indications from common ginger.

Why is zerumbone called the shampoo ginger component?
Zingiber zerumbet is called shampoo ginger (or pinecone ginger) because the mature flower spike accumulates a clear, viscous, foamy sap in its bracts that was used by indigenous peoples across Southeast Asia and Pacific Islands as a shampoo and hair conditioner. The sap contains zerumbone and other sesquiterpenes with antimicrobial and anti-inflammatory properties. This traditional hair-care application aligns with zerumbone’s antimicrobial activity against scalp microorganisms and its anti-inflammatory effects on the scalp skin.

Related compounds: Zingiberene, Gingerol, Parthenolide, Curcumin

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery